317 related articles for article (PubMed ID: 8755353)
21. [Tics and Tourette's syndrome].
Jankovic J; Růzicka E
Cas Lek Cesk; 1997 Jun; 136(13):399-404. PubMed ID: 9333513
[TBL] [Abstract][Full Text] [Related]
22. [Disorders associated with the Gilles de la Tourette syndrome].
Muñoz-Yunta JA; Freixas A; Valls-Santasusana A; Gómez C
Rev Neurol; 1999 Feb; 28 Suppl 2():S156-9. PubMed ID: 10778506
[TBL] [Abstract][Full Text] [Related]
23. Neurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome.
Kurlan R; Kersun J; Ballantine HT; Caine ED
Mov Disord; 1990; 5(2):152-5. PubMed ID: 2325677
[TBL] [Abstract][Full Text] [Related]
24. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
Erenberg G
Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
[TBL] [Abstract][Full Text] [Related]
25. Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder.
Cheon KA; Ryu YH; Namkoong K; Kim CH; Kim JJ; Lee JD
Psychiatry Res; 2004 Jan; 130(1):85-95. PubMed ID: 14972371
[TBL] [Abstract][Full Text] [Related]
26. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome.
Steeves TD; Fox SH
Prog Brain Res; 2008; 172():495-513. PubMed ID: 18772048
[TBL] [Abstract][Full Text] [Related]
27. Tic disorders of childhood.
Clementz GL; Lee RH; Barclay AM
Am Fam Physician; 1988 Aug; 38(2):163-70. PubMed ID: 3044053
[TBL] [Abstract][Full Text] [Related]
28. The Rorschach test and Gilles de la Tourette's syndrome: a pilot case-control study.
Balottin U; Rossi M; Rossi G; Viganò L; Nanti M; Salini S; Lanzi G; Termine C
Brain Dev; 2009 Oct; 31(9):657-65. PubMed ID: 19041203
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory deficits in Tourette syndrome: a function of comorbidity and symptom severity.
Ozonoff S; Strayer DL; McMahon WM; Filloux F
J Child Psychol Psychiatry; 1998 Nov; 39(8):1109-18. PubMed ID: 9844981
[TBL] [Abstract][Full Text] [Related]
30. The functional anatomy of Gilles de la Tourette syndrome.
Ganos C; Roessner V; Münchau A
Neurosci Biobehav Rev; 2013 Jul; 37(6):1050-62. PubMed ID: 23237884
[TBL] [Abstract][Full Text] [Related]
31. A fluvoxamine-induced frontal lobe syndrome in a patient with comorbid Gilles de la Tourette's syndrome and obsessive compulsive disorder.
George MS; Trimble MR
J Clin Psychiatry; 1992 Oct; 53(10):379-80. PubMed ID: 1429480
[No Abstract] [Full Text] [Related]
32. Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder.
Rice T; Coffey B
J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):176-9. PubMed ID: 25782100
[No Abstract] [Full Text] [Related]
33. Conversive Gilles de la Tourette syndrome. A case report.
Frías A; Sierra R; Llorens P
Actas Esp Psiquiatr; 2009; 37(2):115-7. PubMed ID: 19401860
[TBL] [Abstract][Full Text] [Related]
34. Impaired neuropsychological functioning in Tourette's syndrome subjects with co-occurring obsessive-compulsive and attention deficit symptoms.
de Groot CM; Yeates KO; Baker GB; Bornstein RA
J Neuropsychiatry Clin Neurosci; 1997; 9(2):267-72. PubMed ID: 9144107
[TBL] [Abstract][Full Text] [Related]
35. Tourette's syndrome.
Kenney C; Kuo SH; Jimenez-Shahed J
Am Fam Physician; 2008 Mar; 77(5):651-8. PubMed ID: 18350763
[TBL] [Abstract][Full Text] [Related]
36. Basal Ganglia volumes in patients with Gilles de la Tourette syndrome.
Peterson BS; Thomas P; Kane MJ; Scahill L; Zhang H; Bronen R; King RA; Leckman JF; Staib L
Arch Gen Psychiatry; 2003 Apr; 60(4):415-24. PubMed ID: 12695320
[TBL] [Abstract][Full Text] [Related]
37. Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome.
Mol Debes NM; Hjalgrim H; Skov L
J Child Neurol; 2008 Sep; 23(9):1017-27. PubMed ID: 18827268
[TBL] [Abstract][Full Text] [Related]
38. Increased event-related theta activity as a psychophysiological marker of comorbidity in children with tics and attention-deficit/hyperactivity disorders.
Yordanova J; Heinrich H; Kolev V; Rothenberger A
Neuroimage; 2006 Aug; 32(2):940-55. PubMed ID: 16730196
[TBL] [Abstract][Full Text] [Related]
39. [Genetic linkage analysis of Gilles de la Tourette Syndrome in a Colombian family].
García-Cerén JJ; Valencia-Duarte AV; Cornejo JW; Carrizosa J; Cuartas JM; Zuluaga-Espinosa NA; Bedoya G; Ruiz-Linares A
Rev Neurol; 2006 Feb 16-28; 42(4):211-6. PubMed ID: 16521059
[TBL] [Abstract][Full Text] [Related]
40. [Gilles de la tourette syndrome: clinical spectrum and management].
Calderón González R; Calderón Sepúlveda RF
Rev Neurol; 2003 Apr 1-15; 36(7):679-88. PubMed ID: 12666050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
